The series follows the Teslers as they are joined by other Rett families on adaptive adventures across the
'We believe it's crucial to showcase the incredible spirit of individuals living with Rett syndrome and all the things they are capable of, despite their symptoms,' said AJ Tesler, Executive Producer and Director of Magnolia's Guide to Adventuring. 'It's been a long journey for our family since Maggie's Rett diagnosis, and we've learned how to make the most of every day by adapting adventures that we can enjoy as a family. She inspired us to make this series as a celebration of the uniqueness of each person and family affected by Rett syndrome in hopes that we can inspire all families to create their own adventures.'
'At Acadia we have had the privilege of working closely with the Rett syndrome community and have learned a lot about the lives of individuals and families living with this condition. Their journeys teach us that despite the challenges they may face, they possess remarkable abilities often unseen at first glance,' said
About the Filmmakers: AJ &
AJ Tesler is an award-winning television, film, and new media producer and director who has created thousands of hours of content for the likes of Netflix,
About Rett Syndrome
Rett syndrome is a rare, complex, neurodevelopmental disorder that may occur over four stages and affects approximately 6,000 to 9,000 patients in the
Symptoms of Rett syndrome may also include development of hand stereotypies, such as hand wringing and clapping, and gait abnormalities.8 Most Rett patients typically live into adulthood and require round-the-clock care.
About
Acadia is advancing breakthroughs in neuroscience to elevate life. For 30 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized treatment options for people living with hallucinations and delusions associated with Parkinson's disease psychosis and Rett syndrome. Our clinical-stage development efforts are focused on Prader-Willi syndrome, Alzheimer's disease psychosis and multiple other programs targeting neuropsychiatric symptoms in central nervous system disorders.
Contact:
Tel: (858) 261-2872
Email: ir@acadia-pharm.com
Tel: (858) 261-2950
Email: ir@acadia-pharm.com
(C) 2024 Electronic News Publishing, source